Pfizer's Bextra Marketing 'Deceptive': Blue Cross

Law360, New York (October 8, 2008, 12:00 AM EDT) -- In the latest legal headache for Pfizer Inc. over Bextra, Blue Cross and Blue Shield of Kansas Inc. has refreshed its allegations accusing the pharmaceutical giant of manipulating consumers and third-party payers into paying higher prices for the painkiller, which has become the subject of a massive product liability multidistrict litigation in the wake of safety concerns.

Pfizer engaged in a “deceptive and misleading” marketing campaign in an attempt to conceal information that resulted in billions of dollars in overcharges for the costs of Bextra, which...
To view the full article, register now.